342 related articles for article (PubMed ID: 34638632)
1. Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer's Disease.
Gil L; Niño SA; Guerrero C; Jiménez-Capdeville ME
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638632
[TBL] [Abstract][Full Text] [Related]
2. Formaldehyde, Epigenetics, and Alzheimer's Disease.
Wang F; Chen D; Wu P; Klein C; Jin C
Chem Res Toxicol; 2019 May; 32(5):820-830. PubMed ID: 30964647
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease.
Yu CC; Jiang T; Yang AF; Du YJ; Wu M; Kong LH
Neural Plast; 2019; 2019():6856327. PubMed ID: 31093272
[TBL] [Abstract][Full Text] [Related]
4. Aging and Alzheimer's disease connection: Nuclear Tau and lamin A.
Gil L; Niño SA; Capdeville G; Jiménez-Capdeville ME
Neurosci Lett; 2021 Apr; 749():135741. PubMed ID: 33610669
[TBL] [Abstract][Full Text] [Related]
5. Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in aging and Alzheimer's human brains.
Klein HU; McCabe C; Gjoneska E; Sullivan SE; Kaskow BJ; Tang A; Smith RV; Xu J; Pfenning AR; Bernstein BE; Meissner A; Schneider JA; Mostafavi S; Tsai LH; Young-Pearse TL; Bennett DA; De Jager PL
Nat Neurosci; 2019 Jan; 22(1):37-46. PubMed ID: 30559478
[TBL] [Abstract][Full Text] [Related]
6. Early epigenetic changes of Alzheimer's disease in the human hippocampus.
Blanco-Luquin I; Acha B; Urdánoz-Casado A; Sánchez-Ruiz De Gordoa J; Vicuña-Urriza J; Roldán M; Labarga A; Zelaya MV; Cabello C; Méndez-López I; Mendioroz M
Epigenetics; 2020 Oct; 15(10):1083-1092. PubMed ID: 32233750
[TBL] [Abstract][Full Text] [Related]
7. Pathological Nuclear Hallmarks in Dentate Granule Cells of Alzheimer's Patients: A Biphasic Regulation of Neurogenesis.
Gil L; Chi-Ahumada E; Niño SA; Capdeville G; Méndez-Torres AM; Guerrero C; Rebolledo AB; Olazabal IM; Jiménez-Capdeville ME
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361662
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Tau and Its Potential Role in Alzheimer's Disease.
Bukar Maina M; Al-Hilaly YK; Serpell LC
Biomolecules; 2016 Jan; 6(1):9. PubMed ID: 26751496
[TBL] [Abstract][Full Text] [Related]
9. Perinuclear Lamin A and Nucleoplasmic Lamin B2 Characterize Two Types of Hippocampal Neurons through Alzheimer's Disease Progression.
Gil L; Niño SA; Chi-Ahumada E; Rodríguez-Leyva I; Guerrero C; Rebolledo AB; Arias JA; Jiménez-Capdeville ME
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155994
[TBL] [Abstract][Full Text] [Related]
10. The role of tau phosphorylation in the pathogenesis of Alzheimer's disease.
Mi K; Johnson GV
Curr Alzheimer Res; 2006 Dec; 3(5):449-63. PubMed ID: 17168644
[TBL] [Abstract][Full Text] [Related]
11. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
12. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
Navarrete LP; Pérez P; Morales I; Maccioni RB
Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
[TBL] [Abstract][Full Text] [Related]
13. Nuclear tau, a key player in neuronal DNA protection.
Sultan A; Nesslany F; Violet M; Bégard S; Loyens A; Talahari S; Mansuroglu Z; Marzin D; Sergeant N; Humez S; Colin M; Bonnefoy E; Buée L; Galas MC
J Biol Chem; 2011 Feb; 286(6):4566-75. PubMed ID: 21131359
[TBL] [Abstract][Full Text] [Related]
14. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
[TBL] [Abstract][Full Text] [Related]
15. Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies.
Ferreira A; Bigio EH
Mol Med; 2011; 17(7-8):676-85. PubMed ID: 21442128
[TBL] [Abstract][Full Text] [Related]
16. Aging dependent effect of nuclear tau.
Gil L; Federico C; Pinedo F; Bruno F; Rebolledo AB; Montoya JJ; Olazabal IM; Ferrer I; Saccone S
Brain Res; 2017 Dec; 1677():129-137. PubMed ID: 28974363
[TBL] [Abstract][Full Text] [Related]
17. Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes.
Ksiezak-Reding H; He D; Gordon-Krajcer W; Kress Y; Lee S; Dickson DW
Cell Motil Cytoskeleton; 2000 Nov; 47(3):236-52. PubMed ID: 11056524
[TBL] [Abstract][Full Text] [Related]
18. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
[TBL] [Abstract][Full Text] [Related]
19. Post-translational modifications of tau protein in Alzheimer's disease.
Gong CX; Liu F; Grundke-Iqbal I; Iqbal K
J Neural Transm (Vienna); 2005 Jun; 112(6):813-38. PubMed ID: 15517432
[TBL] [Abstract][Full Text] [Related]
20. Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease.
Mano T; Nagata K; Nonaka T; Tarutani A; Imamura T; Hashimoto T; Bannai T; Koshi-Mano K; Tsuchida T; Ohtomo R; Takahashi-Fujigasaki J; Yamashita S; Ohyagi Y; Yamasaki R; Tsuji S; Tamaoka A; Ikeuchi T; Saido TC; Iwatsubo T; Ushijima T; Murayama S; Hasegawa M; Iwata A
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9645-E9654. PubMed ID: 29042514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
